• Undergraduate: Tufts University, Boston, MA
  • Medical School: Tufts University School of Medicine, Boston, MA
  • Internship: Roger Williams Medical Center, Providence, RI
  • Residency: Nassau University Medical Center, East Meadow, NY
  • Fellowship: Retina Specialists of Alabama, Birmingham, AL
About Anthony J. Correnti

Dr. Correnti is a board certified ophthalmologist and a fellowship-trained retina specialist. He has extensive experience in the treatment of retinal diseases including age-related macular degeneration and diabetic retinopathy. He is also available for diabetic eye exams and routine eye care.

Dr. Correnti devotes a significant amount of his free time to help residents of NH who are visually impaired. He is an active board member for the NH Association for the Blind, whose mission is to help people with vision loss continue to live independently. Dr. Correnti is also a member of the local Lions Club in Bedford. As the committee chairman for Operation KidSight, Dr. Correnti is helping to provide vision screening in the local community for children. The screening program is aimed to detect early vision problems such as 'misaligned eyes' (strabismus) and 'lazy eye' (amblyopia).

When away from the office, Dr. Correnti enjoys spending time with his family. He is an avid treasure hunter, hiker, pizza maker, and bocce player.


  • Member of Union Leader’s 40 Under Forty Class of 2016
  • Voted ‘Top Doctor’ in New Hampshire Magazine 2015
  • Voted among ‘Top Doctors’ in New Hampshire Magazine 2012, 2014, 2016

Past President, NH Society of Eye Physicians and Surgeons


  • American Academy of Ophthalmology
  • American Society of Retina Specialists
  • NH Society of Eye Physicians and Surgeons
  • New England Ophthalmological Society
Hospital Affiliations

  • Elliot Hospital
  • Catholic Medical Center
Research Studies

  • Principal Investigator, OPUS-1 Study, Dry Eye Study
  • Sub-Investigator, VIEW 1 Study, Macular Degeneration Study
  • Sub-Investigator, Anecortave Acetate Risk-Reduction Trial, Macular Degeneration Study